Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans

Chinese Medical Journal

Volumn 113, Issue 5, 2000, Pages 433-436

  Wang, Heng ^a   Li, Yuxiu ^a   Sun, Qi ^a   Yang, Guohua ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Fas; Fas ligand; Oral tolerance

Indexed keywords

FAS ANTIGEN; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INSULIN TREATMENT; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET; PROTEIN EXPRESSION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD95; DIABETES MELLITUS, TYPE 1; FEMALE; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD;

EID: 0034034332     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Zhang ZJ, Davidson L, Isenbarth G, et al. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991; 88: 10252-10256.
2. Weiner HL. Commentary oral tolerance. Proc Natl Acad Sci U S A 1994; 91: 10762-10765.
3. Tian J, Atkinson MA, Clare-Slazler M, et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996; 183: 1561-1567.
4. Elias D, Colen IR. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 1995; 44: 1132-1138.
5. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
6. Takeda Y, Gotoh M, Dono K, et al. Protection of islet allografts with Fas ligand expressing testicular allografts. Diabetologia 1998; 41: 315-321.
7. Chervonsky AV, Wang Y, Wong FS, et al. The role of Fas in autoimmune diabetes. Cell 1997; 89: 17-24.